The internal website for DCMB will help staff navigate the department and resources.

A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.

A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.

Congratulations to Kevin Yang (PhD student in the Nesvizhskii lab) on his first first-author publication in "Nature Communications!" 

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

The research describes the creation of a cellular atlas of the kidney describing nearly 100 cell types and states. It represents the most comprehensive study of cellular states, neighborhoods, and outcome-associated signatures in the kidney.

A pediatric cancer patient received new 3D metallic ribs from Spain to help treat and manage her disease.

Physicians, nurse practitioners, social workers, spiritual care professionals, clinical pharmacists and other specialized providers all work together to create a unified palliative care team at Michigan Medicine.

Meet Santhoshi Krishnan, PhD candidate mentored by Arvind Rao, DCMB

Congratulations to Cristina Mitrea and Adam Diehl on your EBS Awards

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.

Matthew O’Meara is promoted to Assistant Professor of DCMB

After an awake surgery to remove a cancerous brain tumor, a Michigan man is living “more deliberately” than ever — officiating a high school wrestling state championship and participating in research for a potential cure.

Research, led by Michigan Medicine and the University of Michigan, suggests that glioblastoma cells are poised near a “critical point” of order and disorder — meaning, the cells possess some form of large-scale coordination throughout the whole tumor that allows them to respond in practical unison to attempts to kill tumor cells, such as chemotherapy or radiation.

The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”